Showing results (411-420 of 421) with videos related to
Sort By:
Pageof 43
Microbial Genomics|July 25, 2022
Replacement of the Alpha variant of SARS-CoV-2 by the Delta variant in Lebanon between April and June 2021Georgi Merhi, Alexander J Trotter, Leonardo de Oliveira Martins, et al.Blood Advances|October 15, 2020
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AMLJayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, et al.Science Translational Medicine|June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemiaJayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.International Journal of Food Microbiology|January 9, 2025
Detection of Echinococcus spp. and other taeniid species in lettuces and berries: Two international multicenter studies from the MEmE projectGérald Umhang, Fanny Bastien, Alexandra Cartet, et al.Psychological Medicine|August 30, 2003
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT studyP Tyrer, S Thompson, U Schmidt, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 15, 2023
Genotyping of European Toxoplasma gondii strains by a new high-resolution next-generation sequencing-based methodM Joeres, P Maksimov, D Höper, et al.Journal of Fish Biology|March 15, 2018
Fishes in a changing world: learning from the past to promote sustainability of fish populationsT A C Gordon, H R Harding, F K Clever, et al.International Journal for Parasitology|January 21, 2024
Mitochondrial genetic diversity and phylogenetic relationships of Echinococcus multilocularis in EuropeAzzurra Santoro, Federica Santolamazza, Simone M Cacciò, et al.The Lancet. Oncology|July 13, 2020
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trialDaniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, et al.Blood|September 15, 2020
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemiaGeoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, et al.Pageof 43